Cortisol
|
Basic information |
| Metabolite name | Cortisol |
 | HMDB0000063 |
 |
C00735 |
 |
657311 |
| Synonyms | NA |
| No. of studies | 19 |
|
Basic information |
| Metabolite name | Cortisol |
| HMDB0000063 |
|
C00735 |
|
657311 |
| Synonyms | NA |
| No. of studies | 19 |
|
Relationship between Cortisol and depression (count: 19) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M084 | Type1 | melancholic depressed group vs. control group | Plasma | Human | Up |
| Study M1087 | Type1 | CSDS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M1120 | Type1 | depressive group vs. control group | Hair | Human | Down |
| Study M169 | Type1 | depressed group vs. control group | Urine | Human | Up |
| Study M517 | Type1 | comorbid depression and anxiety group vs. control group | Hair | Human | Up |
| Study M532 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M575 | Type1 | CUMS group vs. control group | Serum | Wistar rat | Down |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Up |
| Study M633 | Type2 | corticosterone + Chrysanthemum morifolium group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Serum | ICR mouse | Up |
| Study M683 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M683 | Type2 | CUMS + low dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M683 | Type2 | CUMS + middle dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M683 | Type2 | CUMS + high dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M689 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M689 | Type2 | CUMS + Danzhi Xiaoyao Powder group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M703 | Type1 | post-partum depression group vs. control group | Hair | Human | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Up |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + Gleditsiae spina group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M831 | Type1 | MDD group vs. control group | Serum | Human | Up |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Urine | Sprague-Dawley rat | Unknown |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Down |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M945 | Type1 | MDD group vs. control group | Serum | Human | Up |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Down |